SCHEMBL21392220

SCHEMBL21392220

Cn1cc(CCC(=O)O)c2cccc(-c3ccncc3)c21

nearest known ligand 0.55

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MCL1 Q07820 6/20 0.55
GSK3B P49841 1/20 0.41
S1PR1 P21453 3/20 0.40
MTNR1A P48039 3/20 0.40
MTNR1B P49286 3/20 0.40
PTGER1 P34995 1/20 0.39
PTGER4 P35408 1/20 0.39
PTGER3 P43115 1/20 0.39
PTGER2 P43116 1/20 0.39
HTT P42858 1/20 0.39
CCNC P24863 1/20 0.39
CDK8 P49336 1/20 0.39
LTB4R Q15722 1/20 0.37
LTB4R2 Q9NPC1 1/20 0.37
HDAC8 Q9BY41 1/20 0.37
ALDH1A1 P00352 1/20 0.37
MAPT P10636 1/20 0.37
CTSG P08311 1/20 0.36
CMA1 P23946 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20935018 0.90 MCL1 (0.51) MCL1GSK3BS1PR1MTNR1AMTNR1B
SCHEMBL21395939 0.81 CMA1 (0.43) MCL1GSK3BPTGER1PTGER4PTGER3
SCHEMBL18029247 0.80 MAPT (0.46) MCL1HTTCCNCCDK8HDAC8
SCHEMBL18509507 0.78 TRPM5 (0.51) MCL1GSK3BPTGER1PTGER4PTGER3
SCHEMBL18509666 0.78 PTGS2 (0.57) GSK3BCTSGCMA1
SCHEMBL18509929 0.77 MCL1 (0.47) MCL1HDAC8MAPT
SCHEMBL21392215 0.77 GSK3B (0.43) GSK3BS1PR1CTSGCMA1
SCHEMBL19872659 0.77 PARP1 (0.44) GSK3BCTSGCMA1
SCHEMBL18509550 0.77 CDK2 (0.51) MCL1GSK3BS1PR1CTSGCMA1
SCHEMBL23226455 0.76 MCL1 (0.39) MCL1S1PR1MTNR1AMTNR1BHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11078467-B2 Highly active self-sufficient nitration biocatalysts UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED (US) 2021-08-03 US disclosed
US-20190292527-A1 HIGHLY ACTIVE SELF-SUFFICIENT NITRATION BIOCATALYSTS UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED (US) 2019-09-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11078467-B2 Highly active self-sufficient nitration biocatalysts POR, CYP4F3, CBR3 MCL1 3164/4885GSK3B 3763/4885S1PR1 4830/4885
US-20190292527-A1 HIGHLY ACTIVE SELF-SUFFICIENT NITRATION BIOCATALYSTS POR, CYP4F3, CBR3 MCL1 3164/4885GSK3B 3763/4885S1PR1 4830/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.